What are recent patents assigned to Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts?

See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.

Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts patents

Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts holds 118 patents in our database, with recent filings and technology areas summarized below.

Company patent statistics
Metric	Value
Total patents	118
Recent patents	58
First publication	Sep 20, 2016
Latest publication	Mar 10, 2026

Filing trend

Year-over-year patent counts for this assignee.

Filing activity over the last five years is rapidly growing.

Patents filed per year
Year	Patents
2016	2
2017	1
2018	12
2019	12
2020	8
2021	10
2022	9
2023	16
2024	14
2025	30
2026	4

Browse patents by year
Year	Patents
2016	2
2017	1
2018	12
2019	12
2020	8
2021	10
2022	9
2023	16
2024	14
2025	30
2026	4

Recent patents

Latest publications where this party is an assignee.

Method and system for context-aware photoacoustic imaging
US-12569142-B2 · Mar 10, 2026 · US
Method for classification of cancer
US-2026058010-A1 · Feb 26, 2026 · US
DNA-replication associated (Rep) protein antibody
US-12534523-B2 · Jan 27, 2026 · US
Method for predicting the clinical response of oncolytic parvovirus H1 (H-1PV) treatment in a patient suspected of suffering from cancer by measuring the expression levels of laminins and/or galectins as biomarkers in a patient's sample
US-12516381-B2 · Jan 6, 2026 · US
Multi-species chip to detect dna-methylation
US-2025388964-A1 · Dec 25, 2025 · US

Notable patents

Representative or frequently cited publications from precomputed assignee stats.

Method and system for context-aware photoacoustic imaging
US-12569142-B2 · Mar 10, 2026 · US
Method for classification of cancer
US-2026058010-A1 · Feb 26, 2026 · US
DNA-replication associated (Rep) protein antibody
US-12534523-B2 · Jan 27, 2026 · US
Method for predicting the clinical response of oncolytic parvovirus H1 (H-1PV) treatment in a patient suspected of suffering from cancer by measuring the expression levels of laminins and/or galectins as biomarkers in a patient's sample
US-12516381-B2 · Jan 6, 2026 · US
Multi-species chip to detect dna-methylation
US-2025388964-A1 · Dec 25, 2025 · US

Technology areas

Mapped technology topics for this assignee.

Company technology slices
Technology	Patents
Chemistry & Metallurgy	87
Human Necessities	85
Physics	53
Cross-Sectional Technologies	5
Operations & Transport	2
Electricity	1

Frequently asked questions

Answers are generated from the same data shown on this page.

How many patents does Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts have in patentsdb?: Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts is linked to 118 publications as assignee in our database.
What technology areas does Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts patent most?: Top mapped technology areas by patent count: Chemistry & Metallurgy (87); Human Necessities (85); Physics (53).
Is Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts's patent activity growing?: In our data, assignee counts were 14 in 2024 and 30 in 2025 (higher year over year).
What are recent patents assigned to Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rechts?: See the “Recent patents” section above for the latest 5 publications we attribute to this assignee.